Lumida
/DH
⌘K
Definitive Healthcare Corp

Definitive Healthcare Corp

DH
$1.05USD+1.94%+0.02 today

MARKET CAP

152.1M

P/E (TTM)

FWD P/E

DAY RANGE

$1 – $1

52W RANGE

$1
$4

AI Summary

Stalk
Buy NowHigh

DH remains in a long-term downtrend below the declining 200-day SMA, but a pronounced lockout rally driven by short covering and strong volume creates medium-term bullish asymmetry. Under lockout rally dynamics, participation is justified immediately despite extreme overbought conditions, supported by attractive free cash flow fundamentals and elevated short interest. Key risks include a reversal under heavy profit-taking or failure to sustain above intermediate EMAs.

  • Advent International’s takeover offer at $1.02/share sent stock up from ~$0.64
  • Q2 revenue $55.2 M down 9% YoY but EPS $0.05 beat $0.04 estimate
  • Q2 revenue fell 9% YoY to $55.2 M; net loss $(7.5) M improved from $(9.3) M
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$166.2M$222.7M$251.4M$252.2M$241.5M
YoY %+34.0%+12.9%+0.3%-4.2%
P / Sales15.1x5.1x4.6x1.9x1.3x
EV / Sales16.5x7.3x6.5x3.4x2.1x
Gross Profit, Adj.$125.5M$180.0M$203.9M$197.5M$183.3M
YoY %+43.5%+13.3%-3.2%-7.2%
Margin %75.5%80.9%81.1%78.3%75.9%
EV / Gross Profit21.9x9.0x8.0x4.3x2.7x
EBITDA, Adj.$43.7M$29.6M$33.8M$57.4M$51.4M
YoY %-32.4%+14.3%+69.7%-10.4%
Margin %26.3%13.3%13.4%22.7%21.3%
EV / EBITDA62.7x55.0x48.5x14.9x9.7x
EBIT$-27.3M$-44.0M$-329.8M$-710.8M$-224.3M
YoY %-61.2%-648.8%-115.5%+68.4%
Margin %-16.4%-19.8%-131.2%-281.8%-92.9%
EV / EBIT-100.4x-36.9x-5.0x-1.2x-2.2x
Net Income$-17.8M$-7.2M$-202.4M$-413.1M$-138.9M
YoY %+59.5%-2702.4%-104.1%+66.4%
Net Margin-10.7%-3.2%-80.5%-163.8%-57.5%
EPS (GAAP)-$0.19-$0.07-$1.79-$3.54-$1.30
YoY %+63.2%-2457.1%-97.8%+63.3%